Clinical Trial Update: Mesalazine Oral Suspension in Active Eosinophilic Esophagitis [Phase 2]

View source ↗

Summary

Phase 2 trial update for mesalazine oral suspension in active eosinophilic esophagitis completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Eosinophilic Esophagitis

Drugs mentioned

• Mesalazine oral suspension (mesalazine)

Snippet

Sponsor: Dr. Falk Pharma GmbH | Conditions: Eosinophilic Esophagitis | Phase 2 | Status: COMPLETED